Methimazole (Tapazole) Cost in North Dakota 2026

What Is Methimazole and Why Does Cost Matter in North Dakota?

Methimazole is a thionamide antithyroid drug used to manage hyperthyroidism caused by Graves disease, toxic multinodular goiter, and toxic adenoma. It works by blocking thyroid peroxidase, the enzyme that incorporates iodine into thyroid hormone precursors. North Dakota has a largely rural population spread across 70,698 square miles, which means pharmacy access and price transparency matter more than they might in a dense urban market.

Graves disease affects roughly 1 in 200 Americans at some point in their lifetime, and methimazole is the preferred medical therapy in most guidelines [1]. The American Thyroid Association's 2016 guidelines state: "Methimazole should be used in virtually every patient who chooses antithyroid drug therapy" [2]. Because patients with Graves disease may take methimazole for 12 to 18 months or longer during a standard remission trial, even a $20 monthly cost difference compounds to $240 to $360 over a full course of treatment [2].

Understanding your specific cost in North Dakota, whether you are uninsured, on Medicaid, or carrying commercial insurance, determines which access pathway is right for your situation.

Retail Cash Price for Methimazole in North Dakota in 2026

Generic methimazole costs approximately $15 per month at North Dakota retail pharmacies in 2026. That figure applies to the most common dosing scenario: methimazole 10 mg tablets taken once or twice daily, purchased without insurance or a discount card.

Pfizer's branded Tapazole carries a list price near $80 per month, but almost no patient paying cash should pay that rate. The FDA approved generic methimazole from multiple manufacturers, and those generics are therapeutically equivalent to Tapazole [3]. At Bismarck and Fargo retail chains, GoodRx and similar coupon platforms routinely quote methimazole 5 mg (60 tablets) below $12 and methimazole 10 mg (30 tablets) below $14. Prices vary by pharmacy; Walmart and Costco pharmacies in Fargo have historically offered some of the lowest cash prices in the state.

The NEJM landmark trial by Cooper et al. (2005) confirmed methimazole's clinical superiority to propylthiouracil (PTU) for most patients, noting faster TSH normalization and a more tolerable side-effect profile [4]. That clinical preference means the drug your prescriber is most likely to write is also the one with the best generic pricing.

Dose titration affects cost. Patients starting at 20 to 40 mg per day during initial thyroid storm management will spend more on tablets than patients on a 5 mg maintenance dose. If your dose changes, re-run a GoodRx search for your specific quantity before filling, because coupon prices vary non-linearly with tablet count.

North Dakota Medicaid Coverage for Methimazole

North Dakota Medicaid does not cover methimazole as of 2026. This is a coverage gap worth planning around before your first fill.

ND Medicaid (Healthy Steps) follows a preferred drug list (PDL) that changes quarterly [5]. Methimazole's absence from coverage is notable because the drug is on the World Health Organization Essential Medicines List as a critical thyroid therapy [6]. Patients enrolled in ND Medicaid who need methimazole have three realistic options: (1) request a prior authorization for a medical exception, (2) use a 503A compounding pharmacy that may provide the drug at no charge or reduced charge depending on the prescriber's arrangement, or (3) pay the cash price directly, which at roughly $15 per month is lower than many Medicaid copays for covered branded drugs.

Prior authorization submissions to ND Medicaid should include documentation of a confirmed hyperthyroid diagnosis (suppressed TSH below 0.4 mIU/L, elevated free T4 or T3), the prescribing endocrinologist's or primary care physician's clinical notes, and evidence that no covered alternative is medically appropriate. Radioactive iodine therapy and thyroidectomy are procedural alternatives, but they are not medically equivalent choices for every patient, particularly pregnant women and those who decline those procedures [2].

Patients under 18 should also check the Children's Health Insurance Program (CHIP) formulary separately, as pediatric coverage determinations sometimes differ from adult Medicaid PDL decisions [5].

Compounded Methimazole in North Dakota: What Is Legal and What It Costs

Compounded methimazole from a 503A pharmacy is legal in North Dakota and can cost $0 per month for patients whose prescribers work with specific compounding pharmacies. The $0 figure reflects practices where compounding fees are bundled into a telehealth or clinic membership fee rather than charged per prescription.

Under Section 503A of the Federal Food, Drug, and Cosmetic Act, a licensed pharmacist may compound methimazole for an individual patient based on a valid prescription from a licensed practitioner [7]. North Dakota Board of Pharmacy rules align with federal 503A requirements and do not prohibit compounded antithyroid preparations for individual patients [8]. The compounder must use USP-grade active pharmaceutical ingredients, and the compounded product cannot be a copy of a commercially available drug if the commercial version is readily available and appropriate for the patient, which is a regulatory nuance that prescribers and pharmacists manage case by case [7].

Clinically, compounded methimazole preparations are sometimes prescribed as oral solutions or transdermal gels. The oral solution format is useful for pediatric patients or adults with swallowing difficulties. Transdermal methimazole, applied to the pinna of the ear or inner wrist, is most familiar from veterinary use in cats, but some compounding pharmacies do prepare it for human patients. The evidence base for transdermal bioavailability in humans is limited; a 2003 study published in the Journal of Clinical Endocrinology and Metabolism found significantly lower and more variable plasma methimazole concentrations from transdermal vs. oral delivery in human subjects [9]. Prescribers should factor in that data before choosing a transdermal route.

North Dakota patients interested in 503A compounding should confirm the pharmacy holds a current ND Board of Pharmacy non-resident or resident compounding pharmacy license, and should ask their prescriber to verify that the compound formulation is appropriate for their specific thyroid hormone targets.

Insurance Coverage for Methimazole in North Dakota

Most commercial insurance plans in North Dakota cover generic methimazole, though tier placement and copay amounts vary by plan. Methimazole's generic status generally places it on Tier 1 or Tier 2 formulary positions for plans offered through Blue Cross Blue Shield of North Dakota, Sanford Health Plan, and the state employee benefits program [10].

Tier 1 copays on ACA marketplace plans in North Dakota typically run $5 to $15 per fill. Tier 2 copays are commonly $25 to $45. Because the cash price for generic methimazole already sits near $15, patients on plans with a Tier 2 or Tier 3 copay may pay less by bypassing insurance and using a GoodRx coupon at the pharmacy counter. Pharmacists are legally permitted to process a coupon in lieu of insurance for any prescription, and doing so does not affect your deductible accumulation, which is worth considering early in a plan year before you have met your deductible.

Branded Tapazole is almost always placed on a higher tier than generic methimazole. Without prior authorization documenting a clinical reason for the brand, most ND commercial plans will require a generic substitution or charge a Tier 3 or Tier 4 copay that can reach $60 to $80 per fill, essentially matching the list price.

Medicare Part D plans available in North Dakota vary by plan sponsor. The CMS Medicare Part D formulary lookup tool confirms generic methimazole appears on most Part D formularies at Tier 1 or Tier 2 [11]. Patients in the coverage gap (donut hole) in 2026 pay 25% of the drug cost for generics, which at a $15 base price is roughly $3.75 per fill.

Savings Cards and Patient Assistance Programs

Pfizer's savings card for Tapazole and third-party coupon platforms both reduce out-of-pocket costs, but the generic cash price already undercuts most of them. The practical tool hierarchy in North Dakota looks like this.

GoodRx and RxSaver routinely show generic methimazole at $8 to $14 at Bismarck, Fargo, Grand Forks, and Minot pharmacies. These coupons require no enrollment and no income verification. Print or show the code on your phone at the pharmacy counter.

Pfizer's Tapazole savings card (available at the Pfizer patient assistance portal) may reduce the branded product cost for commercially insured patients, but it does not apply to Medicare or Medicaid patients under federal anti-kickback rules [12]. Given that generic methimazole is therapeutically equivalent and costs a fraction of the brand, most prescribers in North Dakota default to generic unless the patient has a documented intolerance to a specific excipient in the generic formulation.

The NeedyMeds database and Partnership for Prescription Assistance list patient assistance programs (PAPs) that can provide free methimazole to uninsured or underinsured patients who meet income criteria, typically at or below 200% to 400% of the federal poverty level [13]. Applications require proof of income, a prescription, and sometimes a prescriber attestation. Turnaround time averages 2 to 4 weeks, so do not delay starting therapy while waiting for PAP approval; fill a one-month cash supply at the $15 price point while the application processes.

Telehealth Prescribing of Methimazole in North Dakota

Telehealth prescribing of methimazole is legal in North Dakota for established clinical relationships. State law permits synchronous audio-video telemedicine visits to establish a new patient-provider relationship and to prescribe medications including antithyroid drugs, provided the prescriber is licensed in North Dakota and the standard of care is met [14].

This matters for patients in rural counties like Divide, Slope, or Billings, where the nearest endocrinologist may be 150 or more miles away. A telehealth-initiated methimazole prescription combined with a local pharmacy fill or a mail-order pharmacy can bring the total monthly cost to $15 or less with no travel burden.

Lab monitoring still requires in-person blood draws. Standard methimazole monitoring per ATA guidelines includes CBC with differential at baseline and at any sign of fever or sore throat, plus thyroid function tests every 4 to 6 weeks during dose titration [2]. Most rural North Dakota towns have a regional health system lab or a LabCorp / Quest draw site within a reasonable drive. A telehealth prescriber can order labs electronically and review results during follow-up video visits.

The Ryan Haight Act historically required an in-person evaluation before prescribing controlled substances via telemedicine, but methimazole is not a controlled substance, so that restriction does not apply [15]. Prescribers must still comply with ND Board of Medicine telemedicine standards, which require a sufficient patient history, appropriate documentation, and a clinical decision consistent with in-person standards of care.

Monitoring Costs and the Full Cost of Treatment in North Dakota

The drug price is only part of the total cost of managing hyperthyroidism with methimazole. Lab monitoring, thyroid imaging, and endocrinology visits add to the annual burden.

A TSH plus free T4 panel at a North Dakota regional hospital lab typically bills $80 to $150 without insurance. With commercial insurance and a deductible, the first labs of the year may cost full billed rate; subsequent labs after meeting the deductible cost the plan's coinsurance rate. Quest Diagnostics offers a self-pay thyroid panel (TSH, free T4, free T3) for roughly $60 to $90 through its patient-direct portal [16].

The NEJM METEOR trial and subsequent ATA meta-analyses confirm that patients treated with methimazole for 12 to 18 months achieve remission rates of approximately 40% to 50% at 5 years, with remission more likely in patients with small goiters, mild disease, and negative TRAb at treatment start [4]. That remission probability means some patients will complete a defined course of treatment and stop the drug, capping their total medication cost, while others will require long-term maintenance or transition to definitive therapy.

Agranulocytosis, the most serious adverse effect of methimazole, occurs in approximately 0.1% to 0.5% of patients [17]. Any patient on methimazole who develops fever, sore throat, or oral ulcers should stop the drug immediately and go to an emergency department for a stat CBC. That is not a cost issue but a safety instruction that every North Dakota patient on methimazole should receive in writing from their prescriber at initiation.

Comparing Methimazole to Radioactive Iodine and Surgery on a Cost Basis

Methimazole's $15-per-month cash price makes it the lowest-cost first option for most North Dakota patients with Graves disease, but the comparison to radioactive iodine (RAI) and thyroidectomy is more complex over a lifetime horizon.

RAI therapy (iodine-131) is typically a one-time treatment billed at $300 to $600 for the dose itself, plus clinic fees and follow-up labs. Most patients become hypothyroid within 6 to 12 months and then require lifelong levothyroxine, which costs $4 to $10 per month at generic prices [18]. A total thyroidectomy at a North Dakota hospital carries facility and surgeon fees that can exceed $15,000 before insurance, plus anesthesia, pathology, and post-operative parathyroid hormone monitoring.

For a 35-year-old North Dakota patient who takes methimazole for 18 months and achieves remission, the total drug cost at $15 per month is $270, with lab costs adding another $400 to $600, for a rough total of $670 to $870 over the treatment course. That is a substantially lower direct cost than surgery. RAI is cost-competitive over short horizons but carries long-term levothyroxine costs and a small risk of worsening Graves ophthalmopathy, which the ATA flags in its 2016 guidelines [2].

The choice between methimazole, RAI, and surgery is not purely financial and should be made with a thyroid-experienced clinician based on disease severity, TRAb titers, goiter size, ophthalmopathy status, pregnancy plans, and patient preference. Cost data is one input, not a determining factor.

North Dakota-Specific Pharmacy Access Points

North Dakota has 67 counties and a population of roughly 780,000. Retail pharmacy density is lower than national averages in western counties. Key access points for methimazole fills include:

Sanford Health pharmacies (Bismarck, Fargo, and surrounding markets) participate in most commercial formularies and accept GoodRx. Altru Health System in Grand Forks operates both an outpatient pharmacy and an endocrinology specialty service. CHI St. Alexius pharmacies in Bismarck serve patients across south-central ND. For patients in western ND near Williston or Dickinson, mail-order pharmacies (Express Scripts, CVS Caremark, OptumRx) deliver 90-day supplies, which at the generic price would be approximately $30 to $40 for a three-month supply, a modest savings over monthly retail fills.

Patients using a mail-order pharmacy for a 90-day supply should confirm that their prescriber writes for the appropriate quantity and that the pharmacy is licensed in North Dakota if it is a compounding facility [8].